Just as combining different treatments is common for managing these conditions, it might seem logical to combine weight-loss medications for better results
Tirzepatide (Mounjaro for diabetes
longum) are well-studied for reducing gas and bloating in people with IBS and other digestive conditions
Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders, and that GLP-1 receptor agonists show potential for treating people with alcohol use disorder (AUD)
Can Semaglutide benefit me in ways other than weight loss
As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL